These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 3034783
1. Studies of phagocytosis in chronic granulomatous disease. Gaither TA, Medley SR, Gallin JI, Frank MM. Inflammation; 1987 Jun; 11(2):211-27. PubMed ID: 3034783 [Abstract] [Full Text] [Related]
2. Increased phagocytic activity of polymorphonuclear leukocytes of chronic granulomatous disease as determined with flow cytometric assay. Hasui M, Hirabayashi Y, Hattori K, Kobayashi Y. J Lab Clin Med; 1991 Apr; 117(4):291-8. PubMed ID: 1849170 [Abstract] [Full Text] [Related]
3. Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job's) syndrome. Gaither TA, Gallin JI, Iida K, Nussenzweig V, Frank MM. Inflammation; 1984 Dec; 8(4):429-44. PubMed ID: 6240460 [Abstract] [Full Text] [Related]
4. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. Stendahl O, Coble BI, Dahlgren C, Hed J, Molin L. J Clin Invest; 1984 Feb; 73(2):366-73. PubMed ID: 6321554 [Abstract] [Full Text] [Related]
6. Viricidal effect of stimulated human mononuclear phagocytes on human immunodeficiency virus type 1. Chase MJ, Klebanoff SJ. Proc Natl Acad Sci U S A; 1992 Jun 15; 89(12):5582-5. PubMed ID: 1319066 [Abstract] [Full Text] [Related]
9. Role of myeloperoxidase in respiratory burst of human polymorphonuclear leukocytes. Studies with myeloperoxidase-deficient subjects. Dri P, Soranzo MR, Cramer R, Menegazzi R, Miotti V, Patriarca P. Inflammation; 1985 Mar 15; 9(1):21-31. PubMed ID: 2984121 [Abstract] [Full Text] [Related]
10. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes. Katz P, Simone CB, Henkart PA, Fauci AS. J Clin Invest; 1980 Jan 15; 65(1):55-63. PubMed ID: 6243141 [Abstract] [Full Text] [Related]
12. Ethylene formation by polymorphonuclear leukocytes. Role of myeloperoxidase. Klebanoff SJ, Rosen H. J Exp Med; 1978 Aug 01; 148(2):490-506. PubMed ID: 212502 [Abstract] [Full Text] [Related]
13. Studies on phagocytosis in patients with acute bacterial infections. Simms HH, Frank MM, Quinn TC, Holland S, Gaither TA. J Clin Invest; 1989 Jan 01; 83(1):252-60. PubMed ID: 2536044 [Abstract] [Full Text] [Related]
14. Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system. Clark RA, Klebanoff SJ. J Exp Med; 1975 Jun 01; 141(6):1442-7. PubMed ID: 165258 [Abstract] [Full Text] [Related]
15. Hydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases. Briggs RT, Karnovsky ML, Karnovsky MJ. J Clin Invest; 1977 Jun 01; 59(6):1088-98. PubMed ID: 193872 [Abstract] [Full Text] [Related]
16. Myeloperoxidase. Klebanoff SJ. Proc Assoc Am Physicians; 1999 Jun 01; 111(5):383-9. PubMed ID: 10519157 [Abstract] [Full Text] [Related]
19. O-phenylenediamine oxidation by phorbol myristate acetate-stimulated human polymorphonuclear leukocytes: characterization of two distinct oxidative mechanisms. Hassan NF, Campbell DE, Douglas SD. Clin Immunol Immunopathol; 1987 Mar 01; 42(3):274-80. PubMed ID: 3030588 [Abstract] [Full Text] [Related]
20. The role of myeloperoxidase in the microbicidal activity of polymorphonuclear leukocytes. Klebanoff SJ, Rosen H. Ciba Found Symp; 1987 Mar 01; (65):263-84. PubMed ID: 225142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]